Venture capitalist Dr Elaine Stead has been awarded $280,000 in her defamation case against the Nine-owned Australian Financial Review after the Federal Court found she suffered hurt and damage to her reputation through a “targeted campaign of offensive mockery” about her role in collapsed investment firm Blue Sky Alternative Investments.
Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer’s Wyeth over the top selling Prevnar 13 pneumococcal vaccine.
Botox maker Allergan has appealed a court judgment tossing most of trade mark case against an Australian cosmetics company that sells topical creams as Botox alternatives.
Trial is set to begin February 2 in a $100 million shareholder class action against Woolworths over a February 2015 profit downgrade that allegedly led to a drop in the company’s share price.
Building products supplier Wagners has successfully challenged a Queensland Supreme Court judgment ruling in favour of Boral in a high-stakes cement supply dispute between the construction giants.
Pfizer unit Wyeth is seeking to overturn part of a judge’s decision in its high-stakes patent dispute with Merck Sharp & Dohme that found claims in two of its patents relating to the blockbuster Prevnar 13 pneumococcal vaccine were invalid.
The Full Federal Court has upheld an appeal by In-N-Out Burgers against Sydney-based Hashtag Burgers, finding that its two sole directors were also liable for trademark infringement and passing off in owning and operating their ‘DOWN-N-OUT’ burger restaurants.
A former University of Sydney lecturer has appealed a ruling dismissing the lawsuit he brought against the university after he was fired for a seminar slide that imposed the Nazi swastika on the Israeli flag and which was later posed on social media.
Three unions representing Qantas workers have asked the High Court for special leave to appeal a ruling from the Full Federal Court siding with the airline in a dispute over the operation of the JobKeeper wage subsidy.
Two psychiatrists at the heart of the Chelmsford deep sleep therapy scandal have launched an appeal of a decision dismissing their defamation case against HarperCollins as an attempt to “rewrite history” regarding the harm done to those receiving the controversial treatment.